Try our Advanced Search for more refined results

March 20, 2020

MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC.

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. March 23, 2020

    Mitsubishi, Janssen Seek To Block Generic Diabetes Drug

    Mitsubishi Tanabe Pharma and the licensees of its diabetes drug Invokamet XR have hit generic-drug manufacturer Aurobindo Pharma USA with a patent infringement suit in New Jersey federal court over what they allege to be a hasty attempt to sell generic versions of the medication.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login